@article{mullard_2023,
	title = {2023 {FDA} approvals},
	volume = {23},
	issn = {1474-1784},
	doi = {10.1038/d41573-024-00001-x},
	language = {eng},
	number = {2},
	journal = {Nature Reviews. Drug Discovery},
	author = {Mullard, Asher},
	month = feb,
	year = {2024},
	pmid = {38168801},
	keywords = {Antineoplastic Agents, Drug Approval, Humans, United States, United States Food and Drug Administration},
	pages = {88--95},
}

@article{Pinero2019,
author = {Pi{\~{n}}ero, Janet and Ram{\'{i}}rez-Anguita, Juan Manuel and Sa{\"{u}}ch-Pitarch, Josep and Ronzano, Francesco and Centeno, Emilio and Sanz, Ferran and Furlong, Laura I},
doi = {10.1093/nar/gkz1021},
issn = {0305-1048},
journal = {Nucleic Acids Research},
month = {nov},
title = {{The DisGeNET knowledge platform for disease genomics: 2019 update}},
url = {https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkz1021/5611674},
year = {2019}
}



@article{shang_targeting_2015,
	title = {Targeting the {Notch} pathway: {A} potential therapeutic approach for desmoid tumors},
	volume = {121},
	issn = {1097-0142},
	shorttitle = {Targeting the {Notch} pathway},
	doi = {10.1002/cncr.29564},
	language = {eng},
	number = {22},
	journal = {Cancer},
	author = {Shang, Hui and Braggio, Danielle and Lee, Ya-Jung and Al Sannaa, Ghadah A. and Creighton, Chad J. and Bolshakov, Svetlana and Lazar, Alexander J. F. and Lev, Dina and Pollock, Raphael E.},
	month = nov,
	year = {2015},
	pmid = {26349011},
	pmcid = {PMC4635059},
	keywords = {CCN Intercellular Signaling Proteins, Cell Cycle Checkpoints, Cell Movement, Cell Proliferation, desmoid tumors, Fibromatosis, Aggressive, Humans, Neoplasm Invasiveness, Notch, Receptors, Notch, Repressor Proteins, Signal Transduction, signaling pathways, Tetrahydronaphthalenes, Valine, wingless, γ-secretase inhibitor},
	pages = {4088--4096},
	file = {Full Text:/home/janet/Zotero/storage/R3UG8QXK/Shang et al. - 2015 - Targeting the Notch pathway A potential therapeut.pdf:application/pdf},
}



@article{gounder_nirogacestat_2023,
	title = {Nirogacestat, a γ-{Secretase} {Inhibitor} for {Desmoid} {Tumors}},
	volume = {388},
	issn = {1533-4406},
	doi = {10.1056/NEJMoa2210140},
	language = {eng},
	number = {10},
	journal = {The New England Journal of Medicine},
	author = {Gounder, Mrinal and Ratan, Ravin and Alcindor, Thierry and Schöffski, Patrick and van der Graaf, Winette T. and Wilky, Breelyn A. and Riedel, Richard F. and Lim, Allison and Smith, L. Mary and Moody, Stephanie and Attia, Steven and Chawla, Sant and D'Amato, Gina and Federman, Noah and Merriam, Priscilla and Van Tine, Brian A. and Vincenzi, Bruno and Benson, Charlotte and Bui, Nam Quoc and Chugh, Rashmi and Tinoco, Gabriel and Charlson, John and Dileo, Palma and Hartner, Lee and Lapeire, Lore and Mazzeo, Filomena and Palmerini, Emanuela and Reichardt, Peter and Stacchiotti, Silvia and Bailey, Howard H. and Burgess, Melissa A. and Cote, Gregory M. and Davis, Lara E. and Deshpande, Hari and Gelderblom, Hans and Grignani, Giovanni and Loggers, Elizabeth and Philip, Tony and Pressey, Joseph G. and Kummar, Shivaani and Kasper, Bernd},
	month = mar,
	year = {2023},
	pmid = {36884323},
	pmcid = {PMC11225596},
	keywords = {Adult, Female, Humans, Antineoplastic Agents, Amyloid Precursor Protein Secretases, Double-Blind Method, Fibromatosis, Aggressive, Gamma Secretase Inhibitors and Modulators, Progression-Free Survival, Quality of Life, Tetrahydronaphthalenes, Valine},
	pages = {898--912},
}


@article{ozen_cd55_2017,
	title = {{CD55} {Deficiency}, {Early}-{Onset} {Protein}-{Losing} {Enteropathy}, and {Thrombosis}},
	volume = {377},
	issn = {1533-4406},
	doi = {10.1056/NEJMoa1615887},
	language = {eng},
	number = {1},
	journal = {The New England Journal of Medicine},
	author = {Ozen, Ahmet and Comrie, William A. and Ardy, Rico C. and Domínguez Conde, Cecilia and Dalgic, Buket and Beser, Ömer F. and Morawski, Aaron R. and Karakoc-Aydiner, Elif and Tutar, Engin and Baris, Safa and Ozcay, Figen and Serwas, Nina K. and Zhang, Yu and Matthews, Helen F. and Pittaluga, Stefania and Folio, Les R. and Unlusoy Aksu, Aysel and McElwee, Joshua J. and Krolo, Ana and Kiykim, Ayca and Baris, Zeren and Gulsan, Meltem and Ogulur, Ismail and Snapper, Scott B. and Houwen, Roderick H. J. and Leavis, Helen L. and Ertem, Deniz and Kain, Renate and Sari, Sinan and Erkan, Tülay and Su, Helen C. and Boztug, Kaan and Lenardo, Michael J.},
	month = jul,
	year = {2017},
	pmid = {28657829},
	pmcid = {PMC6690356},
	keywords = {CD55 Antigens, Child, Child, Preschool, Complement Activation, Complement Inactivating Agents, Complement System Proteins, Female, Homozygote, Humans, Immunoglobulin A, Infant, Intestine, Small, Male, Mutation, Pedigree, Protein-Losing Enteropathies, Statistics, Nonparametric, Syndrome, T-Lymphocytes, Thrombosis},
	pages = {52--61},
	file = {Accepted Version:/home/janet/Zotero/storage/BZY5R6RM/Ozen et al. - 2017 - CD55 Deficiency, Early-Onset Protein-Losing Entero.pdf:application/pdf;Full Text:/home/janet/Zotero/storage/4QIQHYW4/Ozen et al. - 2017 - CD55 Deficiency, Early-Onset Protein-Losing Entero.pdf:application/pdf},
}


@article{ozen_evaluating_2024,
	title = {Evaluating the efficacy and safety of pozelimab in patients with {CD55} deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study},
	volume = {403},
	issn = {1474-547X},
	shorttitle = {Evaluating the efficacy and safety of pozelimab in patients with {CD55} deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease},
	doi = {10.1016/S0140-6736(23)02358-9},
	language = {eng},
	number = {10427},
	journal = {Lancet (London, England)},
	author = {Ozen, Ahmet and Chongsrisawat, Voranush and Sefer, Asena Pinar and Kolukisa, Burcu and Jalbert, Jessica J. and Meagher, Karoline A. and Brackin, Taylor and Feldman, Hagit Baris and Baris, Safa and Karakoc-Aydiner, Elif and Ergelen, Rabia and Fuss, Ivan J. and Moorman, Heather and Suratannon, Narissara and Suphapeetiporn, Kanya and Perlee, Lorah and Harari, Olivier A. and Yancopoulos, George D. and Lenardo, Michael J. and {Pozelimab CHAPLE Working Group}},
	month = feb,
	year = {2024},
	pmid = {38278170},
	pmcid = {PMC10979753},
	keywords = {Antibodies, Monoclonal, Child, Edema, Female, Historically Controlled Study, Humans, Male, Protein-Losing Enteropathies, Serum Albumin, Thrombosis, Treatment Outcome},
	pages = {645--656},
}